EMA PUBLISHES GUIDELINES ON DRUGS WITH MODIFIED RELEASE OF ACTIVE SUBSTANCES
October 1st, 2012
BY CARMEN PAUN, IN BRUSSELS
THE EUROPEAN Medicines Agency (EMA) has published fresh guidance on assessing medicines releasing active substances slowly into the human body - both oral medicines and skin patches. Taking account of the difficulty of checking the reliability of these medicines, EMA has advised the pharma sector on their development, notably in vitro testing of medicines whose release of active substances is delayed or prolonged. "It should be demonstrated that the prolonged release product maintains its drug release characteristics regardless ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.